Cleared Traditional

K143310 - MoisturemeterD

K143310 is an FDA 510(k) clearance for MoisturemeterD, manufactured by Delfin Technologies, Ltd.. The device is a Class 2 Gastroenterology & Urology device with product code OBH cleared through the Traditional 510(k) pathway after a 366-day FDA review.

K143310 · Delfin Technologies, Ltd. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2015
Decision
366d
Days
Class 2
Risk

K143310 is an FDA 510(k) clearance for the MoisturemeterD. Classified as Monitor, Extracellular Fluid, Lymphedema, Extremity (product code OBH), Class II - Special Controls.

Submitted by Delfin Technologies, Ltd. (Kuopio, FI). The FDA issued a Cleared decision on November 19, 2015 after a review of 366 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 870.2770 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Delfin Technologies, Ltd. devices

FDA 510(k) Submission Details - K143310

510(k) Number K143310 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 18, 2014
Decision Date November 19, 2015
Days to Decision 366 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
235d slower than avg
Panel avg: 131d · This submission: 366d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

OBH Device Classification - Class 2, Special Controls

Product Code OBH Monitor, Extracellular Fluid, Lymphedema, Extremity
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2770
Definition Measure Impedances In Affected And Unaffected But Opposite Extremity To Periodically Monitor The Level Of Extracellular Fluid Or The Differences In Bioimpedance Between Opposing Extremities For Patients Who Have Been Previously Diagnosed With Unilateral Lymphedema (that Is, In One Affected Extremity)
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Consultant

Buchanan Ingersol and Rooney
Theodore Sullivan

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - OBH Monitor, Extracellular Fluid, Lymphedema, Extremity

All 9
Devices cleared under the same product code (OBH) and FDA review panel - the closest regulatory comparables to K143310.
MoistureMeterD Compact, LymphScanner
K220557 · Delfin Technologies, Ltd. · May 2022
SOZO
K180126 · ImpediMed Limited · Apr 2018
SOZO
K172122 · ImpediMed Limited · Aug 2017
IMPEDIMED - BIS EXTRA CELLULAR FLUID ANALYSIS
K130338 · ImpediMed Limited · May 2013
IMPEDIMED - EXTRACELLULAR FLUID ANALYZER MODEL: L-DEX U400
K100811 · ImpediMed Limited · Nov 2011
IMPEDIMED EXTRA CELLULAR FLUID ANALYSIS, MODEL L-DEX U400
K080825 · Impedimed Pty , Ltd. · Oct 2008